Six-year retrospective follow-up study of safe screening intervals for sight-threatening retinopathy in patients with diabetes mellitus.

Background: We estimate safe screening intervals for sight-threatening diabetic retinopathy (STDR).

Methods: A 6-year retrospective follow-up study to review screening results of two cohorts of patients with diabetes mellitus (DM) was conducted; a cohort free of diabetic retinopathy (DR) and a cohort with mild nonproliferative diabetic retinopathy (NPDR) at baseline. Patients had been screened by means of a nonmydriatic retinal camera.

Risk factors for postoperative hemorrhage after vitrectomy for diabetic retinopathy.

Objective: To identify the potential risk factors for postvitrectomy diabetic vitreous hemorrhage (PDVH).

Methods: A matched case-control nested into a retrospective follow-up study was done to review the surgical results in 68 consecutive eyes undergoing primary pars plana vitrectomy for vitreous hemorrhage. The eyes were divided into two groups based on the presence of PDVH (19 cases and 49 controls) and were matched on surgeon and the date of surgery.

Sandostatin LAR for cystoid diabetic macular edema: a 1-year experience.

We report the clinical outcome of a 46-year-old diabetic patient with cystoid macular edema treated with Sandostatin long-acting release (LAR). Because cystoid changes in both eyes were refractive to conventional treatment (i.e.